Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis
Author(s) -
Gregory J. Fox,
Carole D. Mitnick,
Andrea Benedetti,
Edward D. Chan,
Mercedes C. Becerra,
ChenYuan Chiang,
Salmaan Keshavjee,
WonJung Koh,
Yuji Shiraishi,
Piret Viiklepp,
JaeJoon Yim,
Geoffrey Pasvol,
J. Robert,
Tae Sun Shim,
Sonya Shin,
Dick Menzies
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw002
Subject(s) - medicine , tuberculosis , multiple drug resistance , adjunctive treatment , surgery , drug resistance , biology , pathology , microbiology and biotechnology
Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be used as an adjunct to medical therapy, with the intent of reducing bacterial burden and improving cure rates. We conducted an individual patient data metaanalysis to evaluate the effectiveness of surgery as adjunctive therapy for MDR-tuberculosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom